Skip to main content
logo
X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.290
+0.150 (3.62%)
Apr 17, 2026, 4:00 PM EDT - Market closed

X4 Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
39036412514012164
Market Cap Growth
885.09%189.93%-10.69%16.23%87.57%-38.56%
Enterprise Value
214.33186.92100.1983.393520.54
Last Close Price
4.294.0022.0125.1629.7968.70
PE Ratio
--2.14-3.94-1.47-0.65-0.57
PS Ratio
11.1110.3649.05---
PB Ratio
2.091.955.662.751.631.00
P/TBV Ratio
0.970.916.662.920.850.92
P/FCF Ratio
--4.25-0.96-1.45-1.56-0.90
P/OCF Ratio
--4.25-0.96-1.45-1.57-0.91
EV/Sales Ratio
6.105.3239.18---
EV/EBITDA Ratio
--2.18-0.41-0.78-0.40-0.24
EV/EBIT Ratio
--2.15-0.41-0.78-0.40-0.24
EV/FCF Ratio
--2.18-0.76-0.86-0.45-0.29
Debt / Equity Ratio
0.410.413.471.120.490.59
Debt / EBITDA Ratio
-0.90-0.90-0.32-0.54-0.44-0.47
Debt / FCF Ratio
-0.87-0.90-0.59-0.60-0.50-0.56
Net Debt / Equity Ratio
-0.94-0.94-1.08-1.09-1.13-0.65
Net Debt / EBITDA Ratio
2.052.050.100.520.950.50
Net Debt / FCF Ratio
1.982.050.180.581.080.59
Asset Turnover
0.160.160.02000
Inventory Turnover
1.581.580.57---
Quick Ratio
9.849.843.165.025.505.89
Current Ratio
10.1610.163.415.345.766.27
Return on Equity (ROE)
-75.99%-75.99%-102.26%-161.83%-135.70%-129.30%
Return on Assets (ROA)
-39.79%-39.79%-169.19%-71.06%-64.97%-70.92%
Return on Invested Capital (ROIC)
-670.61%-670.61%-2067.04%-849.42%-475.23%-302.73%
Return on Capital Employed (ROCE)
-45.94%-45.94%-207.09%-83.46%-74.94%-79.51%
Earnings Yield
-20.31%-46.75%-25.40%-67.85%-153.07%-174.24%
FCF Yield
-21.95%-23.55%-104.63%-68.77%-63.90%-111.03%
Buyback Yield / Dilution
-531.04%-531.04%-13.08%-179.91%-146.71%-28.25%
Total Shareholder Return
-531.04%-531.04%-13.08%-179.91%-146.71%-28.25%
Updated Mar 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q